Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?
about
Towards best practice in acute stroke care in Ghana: a survey of hospital servicesWhere will the next generation of stroke treatments come from?Thrombolysis ImPlementation in Stroke (TIPS): evaluating the effectiveness of a strategy to increase the adoption of best evidence practice--protocol for a cluster randomised controlled trial in acute stroke care.A comprehensive review of prehospital and in-hospital delay times in acute stroke care.Stroke units: many questions, some answers.Pharmacotherapy of cerebral ischemia.How to make better use of thrombolytic therapy in acute ischemic stroke.The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.Improving the efficiency of the development of drugs for stroke.Nanotechnology for the detection and therapy of stroke.The next revolution in stroke care.Interventions for acute stroke management in Africa: a systematic review of the evidence.Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.FAmily-Led RehabiliTaTion aftEr Stroke in INDia: the ATTEND pilot study.Future advances in the treatment of acute ischemic strokeAccess to stroke care units in Australian public hospitals: facts and temporal progress
P2860
Q30837395-C5A856C3-CE68-46C0-9877-817173D8E06FQ30979218-E55203E8-7CAE-4B08-8712-19629D738A94Q33593063-E61373E7-282D-4582-8648-0BE1B4D1BF2CQ33671817-BF9E13A1-4915-43F5-AE7A-82EEBA78BC3CQ37399442-DB315844-3F69-4A4B-A439-B39779E18097Q37514167-69AE073F-906B-4DD6-9D08-1BADCA45CACBQ37889116-264278F5-0E11-49F6-A211-F6BB89B5864CQ37955226-586C14F6-4F28-482A-81C0-B60CB2ED0A62Q38019964-5E50265E-89E1-4D7E-AE2C-B93B2CF637E6Q38201415-8B365B6D-494F-494B-B90D-E84749EB2921Q38261542-11503155-E84A-4DB7-8110-5A3A65EFB9DEQ42634559-97FE3275-9521-450C-9ABC-7C350525ECB0Q48452451-A87DA651-5C1A-45DB-B968-0C6C895CE0E9Q52837640-9494FF92-D0BF-49EA-9566-DCE79C514F5BQ58619261-0B779651-FC5F-403F-8BC8-0E84B1DC1465Q58619292-0BC1081A-5D1A-46F7-844A-D723FB2E57C2
P2860
Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Stroke units, tissue plasminog ...... he greatest community benefit?
@ast
Stroke units, tissue plasminog ...... he greatest community benefit?
@en
Stroke units, tissue plasminog ...... he greatest community benefit?
@nl
type
label
Stroke units, tissue plasminog ...... he greatest community benefit?
@ast
Stroke units, tissue plasminog ...... he greatest community benefit?
@en
Stroke units, tissue plasminog ...... he greatest community benefit?
@nl
prefLabel
Stroke units, tissue plasminog ...... he greatest community benefit?
@ast
Stroke units, tissue plasminog ...... he greatest community benefit?
@en
Stroke units, tissue plasminog ...... he greatest community benefit?
@nl
P2093
P2860
P356
P1476
Stroke units, tissue plasminog ...... he greatest community benefit?
@en
P2093
Amanda K Gilligan
Helen M Dewey
Jonathan W Sturm
Richard A L Macdonell
P2860
P304
P356
10.1159/000087705
P407
P577
2005-01-01T00:00:00Z